EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum Hyaluronic Acid is Associated With Disease Severity in Hospitalized Patients With COVID‐19: A Prospective Observational Study

Ting He, Ying Du, Junhui Ma, Wenqiang Yu, Yinshan Li, Tao Wu, Wei Zhao, Junliang Li, Tuotuo Zhang, Yubo Qing, Bing Zhuan

International Journal of Clinical Practice · 2026-01 · 2026 (1)

DOI: 10.1155/ijcp/9930972 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Practice, online erschienen am 02.08.2026. Verfasst von Ting He und 10 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Ningxia.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early identification of patients at risk of developing severe coronavirus disease 2019 (COVID‐19) remains a major clinical challenge. Hyaluronic acid (HA), a key component of the extracellular matrix, has been implicated in inflammatory and immune dysregulation. However, its clinical utility as a biomarker for disease severity in hospitalized COVID‐19 patients has not been fully established.

Methods

This prospective observational study included 262 hospitalized patients with confirmed COVID‐19. Serum HA levels measured at admission were analyzed, and patients were stratified into tertiles. Associations between HA levels and disease severity were evaluated using correlation analysis and multivariable logistic regression. Receiver operating characteristic (ROC) curves were constructed to assess the predictive performance of HA alone and in combination with C‐reactive protein (CRP) and D‐dimer.

Results

HA levels were significantly associated with increased disease severity. Patients in the highest HA tertile exhibited a markedly higher proportion of severe and critical illness compared with lower tertiles. In multivariable logistic regression analysis adjusted for age, sex, hypertension, diabetes mellitus, coronary heart disease, and chronic obstructive pulmonary disease, serum HA (OR = 1.002, 95% CI: 1.001–1.004, p = 0.014), CRP (OR = 1.015, 95% CI: 1.006–1.025, p = 0.002), and D‐dimer (OR = 2.464, 95% CI: 1.208–6.913, p = 0.033) were independently associated with severe COVID‐19. ROC analysis showed that HA alone had moderate predictive performance for severe disease (area under the curve [AUC] = 0.648, 95% CI: 0.574–0.721), whereas the combination of HA, CRP, and D‐dimer demonstrated improved discrimination with an AUC of 0.814 (95% CI: 0.757–0.871).

Conclusions

Serum HA measured at hospital admission was independently associated with COVID‐19 severity. The combination of HA with routinely available laboratory markers showed improved discriminative performance in this single‐center cohort, suggesting potential value for risk stratification. However, clinical implementation should be considered preliminary and requires validation in prospective multicenter studies.

Förderung

  • Key Research and Development Program of Ningxia

Zitieren

APA

He, T., Du, Y., Ma, J., Yu, W., Li, Y., Wu, T., Zhao, W., Li, J., Zhang, T., Qing, Y., & Zhuan, B. (2026). Serum Hyaluronic Acid is Associated With Disease Severity in Hospitalized Patients With COVID‐19: A Prospective Observational Study. International Journal of Clinical Practice, 2026(1). https://doi.org/10.1155/ijcp/9930972

Vancouver

He T, Du Y, Ma J, Yu W, Li Y, Wu T, et al. Serum Hyaluronic Acid is Associated With Disease Severity in Hospitalized Patients With COVID‐19: A Prospective Observational Study. International Journal of Clinical Practice. 2026;2026(1). doi:10.1155/ijcp/9930972

BibTeX
@article{He2026,
  author = {He, Ting and Du, Ying and Ma, Junhui and Yu, Wenqiang and Li, Yinshan and Wu, Tao and Zhao, Wei and Li, Junliang and Zhang, Tuotuo and Qing, Yubo and Zhuan, Bing},
  title = {Serum Hyaluronic Acid is Associated With Disease Severity in Hospitalized Patients With COVID‐19: A Prospective Observational Study},
  journal = {International Journal of Clinical Practice},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ijcp/9930972}
}
Kostenlos starten →